Transplantation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Transplantation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Transplantation Market

The transplantation market size was valued at USD 11.37 billion in 2023, and the market is now projected to grow from USD 12.43 billion in 2024 to USD 26.17 billion by 2032, exhibiting a CAGR of 9.8% during the forecast period of 2024-2032.

The COVID-19 pandemic created significant opportunities on the transplantation market growth as curbing coronavirus outbreak was prioritized. The COVID-19 outbreak affected the worldwide transplantation marketplace due to a decline in transplantation methods globally. The strict guidelines of the pandemic reduced affected people's visits to healthcare experts for those types of procedures. Furthermore, the pandemic also negatively impacted the product sales of outstanding players in the market until the end of 2020.

The transplantation market share globally has been contributed due to the increase in demand for transplantation procedures. The increasing incidence of continual ailments, together with cancer, kidney failure, COPD, and lupus, frequently leads to significant harm to tissues and organs. The surge in organ failures sticks out as a crucial driver for marketplace growth owing to an upward push in transplantation techniques.

Furthermore, there’s been a notable trend of Collaborations between public and private players and FDA approvals for new indications. The market has witnessed numerous strategic collaborations over time. The growing occurrence of organ failure has caused an extreme necessity for these procedures. Therefore, many gamers continuously specialize in building their product portfolios and are also targeted at increasing the range of those methods through collaborations.

Comprehensive Analysis of Transplantation Market

The transplantation market and healthcare industry are rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by product type, application, and end-user. The product types include, immunosuppressive drugs, tissue products, and preservation solutions. However, the application is such as organ transplantation and tissue transplantation.

The North American region is conducive to the global transplantation market, leading to a recall of USD 4.83 billion owing to substantial demand for novel tissue transplantation products. Elements that strengthened the development of the market are high-quality compensation plans and the fast adoption of 3-dimensional (3D) bioprinting throughout the location. Furthermore, the presence of distinguished organizations inside the U.S. and the regulatory approvals for progressive items are a few commonplace contributing factors to the market increase in North America.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Arthrex, Inc. (U.S.), Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation) (U.S.), BioLife Solutions (U.S.), TransMedics (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Zimmer Biomet (U.S.), and Astellas Pharma Inc. (Japan) these market players provide a level-playing competitive landscape.

In August 2023, TransMedics introduced the acquisition of Bridge to Life Ltd. for the technology Ex-Vivo Organ Support System (""EVOSS"") and LifeCradle Heart Preservation Transport System with the intention of expanding its product offerings and symptoms for organ transplantation.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 9.8% from 2024-2032

Unit Value (USD billion)

Segmentation

By Product Type

Tissue Products

Immunosuppressive Drugs

Preservation Solutions

By Application

Organ Transplantation

Tissue Transplantation

By End-user

Hospitals

Transplantation Centers

Others

By Region

North America (By Product Type, By Application, By End-user, and By Country/Sub-Region)

U.S. (By Application)

Canada (By Application)

Europe (By Product Type, By Application, By End-user, and By Country/Sub-Region)

Germany (By Application)

France (By Application)

U.K. (By Application)

Italy (By Application)

Spain (By Application)

Scandinavia (By Application)

Rest of Europe (By Application)

Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-Region)

China (By Application)

Japan (By Application)

India (By Application)

Australia (By Application)

Southeast Asia (By Application)

Rest of Asia Pacific (By Application)

Latin America (By Product Type, By Application, By End-user, and By Country/Sub-Region)

Brazil (By Application)

Mexico (By Application)

Rest of Latin America (By Application)

Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-Region)

GCC (By Application)

South Africa (By Application)

Rest of Middle East & Africa (By Application)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.